Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Public Health Vaccines topic
No spam. Unsubscribe anytime.
Board approves $1 million master vaccine purchase contract; public and supervisors seek clarity on scope
Summary
The board approved a $1,000,000 master contract to purchase vaccines that are not provided directly by federal allocations. Public comment and supervisors pressed staff for clarity about which vaccines and funding sources will be used; county staff said ARPA funds pay for some vaccine programs but this contract covers market purchases of vaccines
The Pima County Board of Supervisors approved a $1,000,000 master purchasing contract on Dec. 17 to buy vaccines and related supplies that the county does not receive directly through federal allocations.
The item, moved and seconded by board members, passed 4–1 with Supervisor Christie voting no. Christie said the agenda description was insufficiently clear about which vaccines would be purchased and questioned why the funds were coming from the general fund rather than previously available COVID or ARPA allocations.
Dr. Garcia (present at the meeting to answer health‑department questions) explained that the contract is a master agreement to cover vaccines the county must buy on the open market — “everything from flu to measles to polio and anything that we don't directly receive from the federal government as part of our allocation,” he said. County Administrator Jan Lesher added that ARPA funds are being used elsewhere in the vaccine program for staffing and other recurring costs but that the market purchase of vaccines (after federal direct allocations have ended) requires a procurement vehicle such as the approved contract.
During the public comment period earlier in the meeting Anne Rose raised concerns about item 24 and asked whether the proposed $1,000,000 included work to address vaccine‑hesitant residents or whether the funding would be “reckless.” Rose asked for “true informed consent” and expressed concern about mRNA technology. Board members acknowledged the comment and answered that the item before them was a procurement contract to buy vaccine supplies that would be used by public‑health programs.
Action: Approve master vaccine purchasing contract (Surgical Government Solutions/McKesson Medical Surgical Government Solutions or equivalent vendor language on agenda). Outcome: Passed 4–1 (Supervisor Christie opposed). The contract is described in board discussion as covering vaccines not supplied by the federal government; staff said a separate ARPA allocation supports operational costs for vaccination programs.
No ordinance or statutory change was made; the vote funded a contract line item and directed procurement to proceed under the approved terms.
